ImmuneCyte

ImmuneCyte is a joint venture of ThermoGenesis Holdings, Inc. (NASDAQ: THMO), aimed at commercializing ThermoGenesis' proprietary cell processing platform, CAR-TXpress™, for use in immune cell banking and cell-based contract development and manufacturing services (CMO/CDMO). ImmuneCyte utilizes the proprietary CAR-TXpress™ platform, a GMP-compliant closed system capable of automatically separating and cryopreserving different components of blood.